BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35085175)

  • 1. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma.
    Mavi ME; Turan BS; Salanci BV; Bozkurt MF
    Clin Nucl Med; 2022 May; 47(5):e395-e396. PubMed ID: 35085175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy Response in a Pediatric Patient With Extracutaneous Juvenile Xanthogranuloma Monitored by FDG PET/CT.
    Wen Z; Zhuang H
    Clin Nucl Med; 2020 Apr; 45(4):303-305. PubMed ID: 32049719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of congenital systemic juvenile xanthogranulomatosis with pulmonary involvement.
    Ataseven E; Kizmazoglu D; Oniz H
    Pediatr Dermatol; 2021 Jul; 38(4):892-894. PubMed ID: 33998710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of
    Chandekar KR; Satapathy S; Sharma A; Taneja N; Tripathi M; Bal C
    J Nucl Med Technol; 2023 Dec; 51(4):335-336. PubMed ID: 37699645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic Multicentric Reticulohistiocytosis on 18F-FDG PET/CT Breast Carcinoma Follow-up.
    Dietz M; Debarbieux S; Righetti M; Harou O; Tordo J
    Clin Nucl Med; 2021 May; 46(5):e253-e255. PubMed ID: 33323726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Widespread Cutaneous Langerhans Cell Histiocytosis Manifested on 18 F-FDG PET/CT.
    Wang L; Zhang Y; Wu H
    Clin Nucl Med; 2022 Oct; 47(10):e647-e648. PubMed ID: 35543631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrobiotic Xanthogranuloma on 18F-FDG PET/CT.
    Eltilib M; Fenner J; Saramago I; Oldan J
    Clin Nucl Med; 2020 Dec; 45(12):967-969. PubMed ID: 32969908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign cephalic histiocytosis progressing into juvenile xanthogranuloma: a non-Langerhans cell histiocytosis transforming under the influence of a virus?
    Rodriguez-Jurado R; Duran-McKinster C; Ruiz-Maldonado R
    Am J Dermatopathol; 2000 Feb; 22(1):70-4. PubMed ID: 10698221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subdural effusion in a CNS involvement of systemic juvenile xanthogranuloma: a case report treated with vinblastin.
    Auvin S; Cuvellier JC; Vinchon M; Defoort-Dhellemes S; Soto-Ares G; Nelken B; Vallée L
    Brain Dev; 2008 Feb; 30(2):164-8. PubMed ID: 17720345
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET-CT in pediatric Langerhans cell histiocytosis.
    Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of juvenile xanthogranuloma.
    Chen Y; Yang Z; Shi J; Qiao Z
    Pediatr Radiol; 2023 Feb; 53(2):265-272. PubMed ID: 36040525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile Xanthogranuloma: An Entity With a Wide Clinical Spectrum.
    Hernández-San Martín MJ; Vargas-Mora P; Aranibar L
    Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):725-733. PubMed ID: 32721389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Presentation of Cutaneous Langerhans Cell Histiocytosis: 18 F-FDG PET/CT Detection of Systemic Disease.
    Robinson E; Nawwar A; Searle J; Lyburn I
    Clin Nucl Med; 2024 Apr; 49(4):333-334. PubMed ID: 38377389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
    Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
    Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
    Asano T; Suzutani K; Watanabe A; Honda A; Mori N; Yashiro M; Sato S; Kobayashi H; Watanabe H; Hazama M; Kanno T; Suzuki E; Ishii S; Migita K
    Medicine (Baltimore); 2018 Aug; 97(33):e11449. PubMed ID: 30113451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile xanthogranuloma with angiomatous appearance and a peculiar immunophenotype.
    López-Robles J; Núñez L; Macias-Del-Toro E; Ramírez-Bellver JL; Díaz JL; Requena L
    Pediatr Dermatol; 2018 Jan; 35(1):e55-e56. PubMed ID: 29165834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of Langerhans Cell Histiocytosis and Ganglioneuroblastoma Revealed by 18 F-FDG PET/CT in a Pediatric Patient.
    Xu Y; Lu X; Wang W; Yang J
    Clin Nucl Med; 2024 Apr; 49(4):371-372. PubMed ID: 38350091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.